Top Markets
Coin of the day
Hansa Biopharma AB Hansa Biopharma AB

Hansa Biopharma AB

HNSBF
Κατάταξη σε μετοχές #15161
Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development... Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe. The company offers Idefirix(imlifidase), which targets and cleaves all classes of immunoglobulin G (IgG) antibodies for the desensitization treatment of sensitized adult kidney transplant patients with a positive crossmatch test. It is also developing HNSA-5487, a next generation IgG-cleaving enzyme to address acute and chronic neuro-autoimmune conditions, including myasthenia gravis. In addition, the company evaluates imlifidase in three therapy areas, including autoimmune, gene therapy, and transplantation. It has a collaboration agreement with Sarepta Therapeutics to assess imlifidase as a pre-treatment in limb-girdle muscular dystrophy (LGMD) and duchenne muscular dystrophy (DMD); AskBio to evaluate imlifidase as a pre-treatment in pompe disease; and research and development collaboration agreement with Genethon to evaluate the safety and efficacy of imlifidase as pre-treatment to gene therapy in Crigler-Najjar syndrome patients with anti-AAV antibodies. Hansa Biopharma AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Τιμή μετοχής
$3.70
Τελευταίος συγχρονισμός: 2026-08-28
Κεφαλαιοποίηση
$369.01M
Αλλαγή (1 ημέρα)
0.00%
Αλλαγή (1 έτος)
35.04%
Χώρα
SE
Εμπόριο Hansa Biopharma AB (HNSBF)

Κατηγορία

Ιστορικό τιμής μετοχής για την Hansa Biopharma AB (HNSBF)
Υψηλότερη τιμή κλεισίματος: $3.70 στις 2026-08-01

Χαμηλότερη τιμή κλεισίματος: $4.71 στις 2015-03-01
Ιστορικό τιμής μετοχής της Hansa Biopharma AB από 2015 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2026 (TTM) 7.87%
2025 -0.21%
2024 29.03%
2023 -54.16%
2022 -51.64%
2021 -65.44%
2020 200.34%
2019 -69.02%
2018 10.98%
2017 118.54%
2016 302.77%
2015 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$61.61 71.22%
US
$51.09 69.52%
SE
$194.53 42.09%
FR
$62.45 0.05%
IT
$113.45 62.73%
US